44911-0724 NDC - TRACE MINERAL CORD (ARGENTUM METALLICUM, AURUM METALLICUM, BORON CITRATE, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CHROMIUM SULPHURICUM, COBALT GLUCONATE, CUPRUM SULPHURICUM, FERRUM PHOSPHORICUM, GERMANIUM SESQUIOXIDE, IODIUM, KALI BROMATUM, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, LITHIUM CARBONICUM, MAGNESIA PHOSPHORICA, MANGANUM MURIATICUM, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, SELENIUM METALLICUM, SILICEA, SODIUM MOLYBDATE, STRONTIUM CARBONICUM, VANADIUM METALLICUM,)

Drug Information

  • Product NDC: 44911-0724
  • Proprietary Name: Trace Mineral Cord
  • Non Proprietary Name: Argentum Metallicum, Aurum Metallicum, Boron Citrate, Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Chromium Sulphuricum, Cobalt Gluconate, Cuprum Sulphuricum, Ferrum Phosphoricum, Germanium Sesquioxide, Iodium, Kali Bromatum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Lithium Carbonicum, Magnesia Phosphorica, Manganum Muriaticum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Selenium Metallicum, Silicea, Sodium Molybdate, Strontium Carbonicum, Vanadium Metallicum,
  • Active Ingredient(s): 8 [hp_X]/mL BORON CITRATE; 8 [hp_X]/mL CALCIUM FLUORIDE; 8 [hp_X]/mL CALCIUM SULFATE ANHYDROUS; 8 [hp_X]/mL CHROMIC SULFATE PENTADECAHYDRATE; 8 [hp_X]/mL COBALTOUS GLUCONATE; 8 [hp_X]/mL CUPRIC SULFATE; 8 [hp_X]/mL DIBASIC POTASSIUM PHOSPHATE; 8 [hp_X]/mL FERROSOFERRIC PHOSPHATE; 8 [hp_X]/mL GERMANIUM SESQUIOXIDE; 8 [hp_X]/mL GOLD; 30 [hp_X]/mL INDIUM; 8 [hp_X]/mL IODINE; 8 [hp_X]/mL LITHIUM CARBONATE; 8 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 8 [hp_X]/mL MANGANESE CHLORIDE; 30 [hp_X]/mL PALLADIUM; 30 [hp_X]/mL PLATINUM; 8 [hp_X]/mL POTASSIUM BROMIDE; 8 [hp_X]/mL POTASSIUM CHLORIDE; 8 [hp_X]/mL POTASSIUM SULFATE; 8 [hp_X]/mL SELENIUM; 8 [hp_X]/mL SILICON DIOXIDE; 8 [hp_X]/mL SILVER; 8 [hp_X]/mL SODIUM CHLORIDE; 8 [hp_X]/mL SODIUM MOLYBDATE; 8 [hp_X]/mL SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; 8 [hp_X]/mL SODIUM SULFATE; 8 [hp_X]/mL STRONTIUM CARBONATE; 8 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE; 8 [hp_X]/mL VANADIUM; 8 [hp_X]/mL ZINC GLUCONATE
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Blood Coagulation Factor [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Cations; Divalent [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Increased Coagulation Factor Activity [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Mood Stabilizer [EPC]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]; Standardized Chemical Allergen [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: Energique, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:12/20/2024

Package Information

No. Package Code Package Description Billing Unit
144911-0724-159 mL in 1 BOTTLE, DROPPER (44911-0724-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC44911-0724The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETrace Mineral CordThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEArgentum Metallicum, Aurum Metallicum, Boron Citrate, Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Chromium Sulphuricum, Cobalt Gluconate, Cuprum Sulphuricum, Ferrum Phosphoricum, Germanium Sesquioxide, Iodium, Kali Bromatum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Lithium Carbonicum, Magnesia Phosphorica, Manganum Muriaticum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Selenium Metallicum, Silicea, Sodium Molybdate, Strontium Carbonicum, Vanadium Metallicum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE12/20/2024This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergique, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBORON CITRATE; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CHROMIC SULFATE PENTADECAHYDRATE; COBALTOUS GLUCONATE; CUPRIC SULFATE; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; GERMANIUM SESQUIOXIDE; GOLD; INDIUM; IODINE; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE CHLORIDE; PALLADIUM; PLATINUM; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SELENIUM; SILICON DIOXIDE; SILVER; SODIUM CHLORIDE; SODIUM MOLYBDATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; STRONTIUM CARBONATE; TRIBASIC CALCIUM PHOSPHATE; VANADIUM; ZINC GLUCONATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 30; 8; 8; 8; 8; 30; 30; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025